Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-08

Clinical Trial Update: The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of SGLT2 inhibitors on cystine stone formation in cystinuria has completed, and results were posted on 2025-10-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of California, San Francisco | Conditions: Cystinuria | Phase 2 | Status: COMPLETED | Results posted: 2025-10-08